Late-Onset Schizophrenia and Psychosis in Older Adults
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
A person may reach their 50s, 60s, or 70s without any known history of psychosis and then begin hearing voices, suspecting that neighbors have installed surveillance devices, or developing fixed beliefs that others find difficult to understand. The experience can be frightening, particularly when family members assume that schizophrenia always begins in youth. Yet new psychotic symptoms in later life have several possible explanations, including treatable medical problems, medication effects, delirium, mood disorders, neurodegenerative conditions, and a primary schizophrenia-spectrum illness.
Late-onset schizophrenia is a research and clinical term commonly used when schizophrenia begins after age 40, while very-late-onset schizophrenia-like psychosis describes a schizophrenia-like presentation beginning after age 60. These age cutoffs come from an international expert consensus; they are useful descriptive groupings rather than separate diagnoses established by DSM-5-TR or ICD-11. A new hallucination or delusion in an older adult calls for a careful clinical assessment, never an assumption that dementia or schizophrenia has already been proven.
This guide explains what these terms mean, what clinicians look for, which medical and neurological conditions may produce similar experiences, how later-life psychosis is investigated and treated, what families can do, and what long-term evidence tells us about prognosis. It focuses on the older-adult question; general symptoms and treatment are covered separately in our schizophrenia overview.
What Is Late-Onset Schizophrenia?
Schizophrenia is a clinical disorder that may involve persistent delusions, hallucinations, disorganized thinking or behavior, negative symptoms, changes in cognition, and impaired functioning. Diagnosis depends on the full symptom pattern, duration, consequences, and exclusion of other explanations. Most first diagnoses occur in adolescence or early adulthood, but first onset can occur later. The National Institute of Mental Health describes this typical earlier age pattern while emphasizing the variation in presentation and response to treatment.
The phrase late-onset schizophrenia ordinarily refers to a first illness onset after 40, usually within the 40–60 age range in the consensus classification. Very-late-onset schizophrenia-like psychosis, often abbreviated VLOSLP in research, refers to a first schizophrenia-like psychotic illness after age 60. Investigators deliberately chose schizophrenia-like psychosis for the older group because its causes, relationship to neurodegeneration, and boundaries with other diagnoses remain under study. The Howard and colleagues consensus paper remains an important historical reference, while contemporary evaluation should follow current diagnostic standards and individual findings.
Neither term means that everyone who develops a psychotic symptom after 40 or 60 has schizophrenia. A person can develop psychosis as part of severe depression, bipolar disorder, a neurological illness, a drug reaction, delirium, or a neurocognitive disorder. This distinction between a symptom syndrome and a diagnosed disorder underlies the entire assessment. Our psychosis overview explains that wider clinical category.
Late-Onset, Very-Late-Onset, and Long-Standing Schizophrenia: The Essential Difference
Schizophrenia beginning after age 40
When psychotic illness first meets schizophrenia criteria in midlife, clinicians examine both the current presentation and earlier functioning. A person may have had subtle changes for years, or the first sustained symptoms may genuinely appear in the 40s or 50s. Retrospective age of onset can be uncertain when earlier experiences were concealed, misinterpreted, or never assessed. Diagnosis follows contemporary schizophrenia criteria rather than simply meeting an age threshold.
Schizophrenia-like psychosis beginning after age 60
First psychosis after 60 warrants especially close scrutiny of medical, cognitive, sensory, and medication-related factors. Some patients display persistent persecutory delusions and hallucinations while retaining substantial independence and relatively organized speech. Others have signs suggesting an evolving neurological condition. The age-based VLOSLP designation is a research framework describing this group; it does not settle etiology or provide an independent DSM-5-TR diagnosis. Reviews of late-onset psychosis emphasize that clinical similarities cannot replace a differential diagnosis.
Growing older with schizophrenia diagnosed decades earlier
An older adult who received a schizophrenia diagnosis at 22 and is now 72 has a different clinical history from someone whose first psychotic episode occurs at 72. In the first case, treatment may focus on long-term maintenance, physical health, mobility, cognitive aging, social connection, and medication burden. In the second, discovering why symptoms have appeared now takes priority. Medical illness and delirium can also occur in someone with established schizophrenia, so new confusion or sudden deterioration still requires investigation.
What Does Psychosis Look Like in Older Adults?
Psychosis describes a disturbance in perception, belief, or thought organization that may include hallucinations and delusions. Delusions are strongly held beliefs that remain resistant to contrary evidence in a clinical context; hallucinations are perception-like experiences without the corresponding external stimulus. Disorganized speech or behavior may also appear. The content of beliefs is shaped by individual experience, culture, living circumstances, and sensory information. Clinicians assess conviction, distress, safety, insight, functioning, and change over time rather than labeling every unusual belief pathological.
Persecutory beliefs and experiences involving the home
A person may become convinced that neighbors are spying through a wall, that personal belongings are repeatedly moved or stolen, or that unfamiliar people enter their apartment. Suspicion in these circumstances requires careful contextual inquiry. Actual exploitation, unsafe housing, financial abuse, interpersonal conflict, memory lapses, and sensory misperceptions can complicate the picture. Clinicians must investigate credible external concerns alongside the possibility of a delusional interpretation.
Hearing voices, seeing figures, and other sensory experiences
Some individuals hear speech when no speaker is present. Others see figures, shadows, animals, or strangers; describe abnormal smells or touch; or misidentify familiar surroundings. Visual hallucinations merit special attention because they can occur in delirium, neurological conditions, medication reactions, visual impairment, and dementia with Lewy bodies. No single sensory modality confirms or excludes schizophrenia. The National Institute on Aging's review of Lewy body dementia describes characteristic visual hallucinations alongside changes in alertness, movement, and sleep.
Negative symptoms, thinking changes, and everyday function
Reduced motivation, emotional expression, speech, and social engagement can accompany schizophrenia, while difficulties with attention, planning, memory, and processing speed may affect daily life. In older adults, similar outward changes can reflect depression, frailty, hearing loss, adverse medication effects, loneliness, physical illness, or neurocognitive decline. The symptom label gains meaning only through a longitudinal assessment. The NIMH description of positive, negative, and cognitive symptoms explains these domains.
Why Can Psychosis First Appear in Later Life?
Late-life psychosis develops through different causal pathways. Primary schizophrenia-spectrum disorders are one possibility; secondary psychosis associated with a medical, neurological, substance-related, or medication-related factor is another. An older person is more likely than a young adult to have multiple illnesses, take several prescription and nonprescription medications, experience hearing or visual decline, and be vulnerable to acute confusion during illness. A clinical review of older-adult acute psychosis therefore recommends a broad assessment before settling on a primary psychiatric explanation.
Research has reported associations between later-onset schizophrenia-like presentations and female sex, sensory impairment, social isolation, and other characteristics. These associations do not mean that living alone, having hearing loss, or being a woman causes schizophrenia. Population samples differ, age cutoffs vary, and many studies cannot disentangle preexisting vulnerability from the consequences of symptoms. The 2022 clinical review summarizes observed patterns and their methodological limitations.
Hearing and vision changes
When hearing is reduced, speech may become incomplete or ambiguous; visual impairments can produce altered visual experiences. In some cases, visual hallucinations occur with preserved insight in conditions associated with reduced sight. Because the person may struggle to communicate exactly what was perceived, clinicians ask whether experiences change with lighting, hearing aids, glasses, or the surrounding environment. Hearing and vision assessment is part of respectful, evidence-informed care, alongside checking for acute medical and psychiatric explanations.
Physical illness, sleep disruption, and the medication burden
Infection, dehydration, metabolic abnormalities, kidney or liver dysfunction, pain, sleep disruption, medication changes, intoxication, and withdrawal can contribute to changes in perception or cognition. The causal link in an individual case depends on timing, examination, medication review, and appropriate tests. Particular attention may be needed for drugs with anticholinergic properties, corticosteroids, dopaminergic medications, sedatives, and complex combinations; clinicians determine whether a specific exposure is plausible and whether stopping or changing it is safe. People should not discontinue prescribed drugs on their own.
Late-Onset Schizophrenia vs. Dementia, Delirium, and Other Disorders
The most important question after a new psychotic presentation in later life is often whether the symptoms arise within a primary psychotic disorder or signal another condition needing different care. More than one condition can coexist, so a prior psychiatric diagnosis does not rule out a new neurological or medical illness. A clinician uses onset speed, attention, cognitive trajectory, associated mood and movement symptoms, physical examination, collateral history, and follow-up to refine the diagnosis.
Delirium: a change over hours or days
Delirium usually involves an acute, often fluctuating disturbance in attention and awareness, potentially with disorientation, altered sleep, hallucinations, agitation, or unusual withdrawal. Someone who becomes suddenly confused during a urinary infection, after surgery, or following a new medication needs prompt medical assessment. Infections are only one possible cause; dehydration, medication toxicity, organ dysfunction, or other acute illness may be responsible. A calm or sleepy presentation can be delirium as well. NICE guideline CG103, updated in 2023, recommends assessment with the 4AT in relevant settings and treating delirium first when diagnosis is unclear.
Dementia and other neurocognitive disorders: progressive change
Neurocognitive disorders may produce delusions, hallucinations, misidentification, or behavioral changes in the context of a decline from prior cognitive abilities. A longstanding, progressively worsening pattern of memory, navigation, judgment, or independent functioning may increase concern about a neurodegenerative process. Some disorders initially affect planning, visual processing, or fluctuating attention more prominently than episodic memory. A normal brief memory screen does not settle the matter; a longitudinal history and appropriately selected cognitive testing may be required.
Dementia with Lewy bodies: hallucinations plus characteristic neurological features
Dementia with Lewy bodies can involve recurrent well-formed visual hallucinations, fluctuating attention or alertness, parkinsonism, and REM sleep behavior disorder. Memory loss need not dominate the earliest presentation. This pattern matters because people with Lewy body dementia may be particularly sensitive to certain antipsychotic medications. Recognition depends on a clinical evaluation and sometimes additional specialized testing. The National Institute on Aging describes these characteristic features and emphasizes the possibility of initial misdiagnosis.
Depression with psychotic features and bipolar disorder
Severe major depression can include psychotic symptoms, sometimes involving guilt, poverty, illness, or perceived wrongdoing; bipolar disorder can include psychosis during manic or depressive episodes. The relationship between psychosis and distinct mood episodes is diagnostically important. Schizoaffective disorder and primary schizophrenia-spectrum conditions have different longitudinal requirements. These are separate diagnostic pathways with their own treatment considerations, and a short interview in the middle of an episode may not reveal the full course. The NICE adult psychosis guidance directs clinicians to mood-disorder guidance when an affective psychosis is suspected.
Delusional disorder, neurological disease, and substance- or medication-induced psychosis
Delusional disorder may involve persistent delusions with comparatively less broad disorganization or functional disturbance than schizophrenia, but a new belief in older age still calls for medical and cognitive evaluation. Seizure-related disorders, Parkinson's disease and its treatments, brain lesions, and other neurological or systemic conditions can be relevant in selected cases. Substance exposure and withdrawal can also produce psychosis. Classification follows the underlying mechanism and evidence when identified. Our article on psychosis due to a medical condition addresses that separate question.
How Clinicians Diagnose New-Onset Psychosis in an Older Adult
There is no single blood test, scan, question, or online symptom checklist that establishes late-onset schizophrenia. The diagnostic process begins by establishing what changed, when it changed, what was happening at the time, and what functioning looked like before the change. Experienced assessment may involve primary care, emergency medicine, geriatric psychiatry, neurology, and other specialists depending on urgency and findings. A detailed history often matters as much as any individual test.
Establishing the timeline
A clinician asks whether symptoms emerged over hours, weeks, months, or years; whether attention fluctuates; whether this is truly the first episode; and whether there were earlier unusual beliefs, functional changes, mood episodes, hospitalizations, neurological symptoms, or cognitive complaints. Family or caregiver observations can help reconstruct the timeline, with the person's knowledge and privacy respected whenever possible. The onset date may remain uncertain, and the differential diagnosis may be revised after follow-up.
Medication, substance, sensory, and safety review
The assessment reviews all prescribed drugs, over-the-counter products, supplements, alcohol or other substances, recent dose changes, withdrawal, sleep, pain, and hearing or vision difficulties. It considers whether the person is eating, drinking, taking medication, maintaining hygiene, navigating their environment, and staying safe at home. Thoughts of self-harm, threatening experiences, command hallucinations, exploitation risk, and capacity for decisions may need direct evaluation. Risk assessment should be individualized and should avoid equating psychosis with violence.
Physical examination and targeted investigations
Examination may include vital signs, hydration status, a general and neurological examination, hearing and vision assessment, attention and cognitive screening, and laboratory investigations guided by history and findings. Depending on the presentation, clinicians may evaluate blood counts, electrolytes, kidney and liver function, glucose, thyroid function, vitamin B12 and folate, inflammatory or infectious indicators, or toxicology. These are examples of potential investigations, not a universal panel required for every patient. A clinical approach to acute psychosis in older adults discusses how tests should address the suspected causes.
Brain imaging may be considered when late-onset psychosis is unexplained, neurological signs are present, cognitive change is concerning, or structural disease is suspected. An MRI or CT scan can identify certain abnormalities, but a normal image does not prove schizophrenia or rule out all neurodegenerative disease. Electroencephalography or more specialized examinations are reserved for appropriate indications such as suspected seizure activity. Diagnostic decisions integrate test results with observed course and clinical history.
Cognitive testing and repeat assessment
Brief cognitive screening can help identify concerns but does not on its own distinguish psychotic illness from depression, delirium, sensory impairment, medication effects, or dementia. Formal neuropsychological evaluation may clarify which abilities are affected and what support is needed. The evaluation should account for language, education, hearing, vision, cultural background, fatigue, and acute illness. When clinicians suspect delirium or an unstable medical condition, assessment and treatment of that condition take precedence over attaching a long-term psychiatric label.
Does Very-Late-Onset Psychosis Mean Dementia Will Develop?
The association between very-late-onset schizophrenia-like psychosis and subsequent dementia is an active research question. A Swedish matched population-based cohort study found a higher rate of later dementia diagnosis among people identified with VLOSLP than among matched individuals without that diagnosis. This is important evidence for ongoing cognitive follow-up, but observational association cannot determine the cause in any one person. Early unrecognized neurodegeneration, shared vulnerability, surveillance differences, and diagnostic overlap are possible explanations.
The study does not establish that every person with late-onset psychosis has dementia or will develop it. Nor does it prove that an individual psychotic episode causes neurodegeneration. Clinicians may monitor changes in memory, attention, daily functioning, movement, sleep, and behavior over time. Some people retain stable cognition and meaningful independence over long periods. Individual predictions require more information than age and symptom type alone.
How Is Late-Onset Schizophrenia Treated?
Treatment starts with the most likely cause and the person's goals. Delirium due to a medical illness needs urgent medical care; medication-induced symptoms may require supervised changes to treatment; a neurological condition may have its own management plan. When a primary schizophrenia-spectrum disorder is established, treatment can combine carefully selected antipsychotic medication, psychological support, family education, sensory and physical-health care, and practical assistance with daily living. Plans should be adapted to comorbidity, frailty, mobility, cognition, personal priorities, and adverse-effect vulnerability.
Antipsychotic medication: potential benefit and special precautions
Antipsychotic drugs can reduce distressing hallucinations and delusions in primary psychotic disorders. Older people may be more susceptible to sedation, orthostatic hypotension, falls, extrapyramidal symptoms, tardive dyskinesia, cardiac effects, metabolic changes, and interactions with other drugs. Selection, starting dose, titration, and monitoring should be individualized by a prescribing clinician, with shared decisions about likely benefits, risks, and the outcomes that matter most to the patient. NICE CG178 recommends assessing physical health and monitoring treatment response and adverse effects systematically.
A controlled trial provides direct evidence in a specific older-adult population. The ATLAS randomized trial evaluated low-dose amisulpride for people with very-late-onset schizophrenia-like psychosis and found improvement in psychotic symptoms relative to placebo over the initial treatment period. That result does not show that one medicine is best for all older adults, nor that its tested regimen should be copied without specialist evaluation. The trial excluded people with substantial cognitive impairment and was conducted in UK specialist services; licensing, availability, and appropriate prescribing differ by country.
The dementia-related psychosis warning
Antipsychotic medicines carry an important warning about increased mortality in older adults with dementia-related psychosis; stroke-related risks are also relevant for some agents. This warning has direct implications when dementia is suspected or confirmed. It should not be casually transferred as an identical risk estimate to every older adult with schizophrenia, but it must inform assessment whenever dementia-related psychosis is a plausible diagnosis. The NIH MedlinePlus drug information describes the warning for aripiprazole, and NIA's Lewy body dementia guidance underscores special antipsychotic sensitivity in that disorder.
What needs monitoring?
Before and during treatment, the care team may assess weight, glucose or HbA1c, lipids, blood pressure, cardiovascular history, electrocardiogram when indicated, movement disorders, sedation, falls, swallowing or constipation problems, hydration, and possible drug interactions. Monitoring frequency depends on medicine, dose, risk, and phase of treatment. Changes in smoking status may also alter the metabolism of some medicines. Regular reviews should check whether symptoms, sleep, relationships, confidence, and real-world functioning have improved enough to justify the continuing burden of treatment.
Clozapine and treatment resistance
Clozapine is an evidence-based option for treatment-resistant schizophrenia after adequate trials of other antipsychotics, but it requires particularly careful clinical supervision. Its risks can include severe neutropenia, constipation and gastrointestinal hypomotility, myocarditis, seizures, sedation, and metabolic adverse effects. Older-adult use demands individualized assessment rather than automatic application of younger-adult protocols. The APA schizophrenia practice guideline and NICE CG178 address treatment resistance and clozapine's role.
CBT for psychosis and other psychological approaches
Cognitive behavioral therapy for psychosis can help people examine distressing interpretations, reduce distress, manage voices or suspicious beliefs, and develop coping strategies that fit personal goals. It is offered as part of a collaborative treatment plan, rather than as an argument intended to force agreement about the person's experiences. Evidence for specific psychological interventions in very-late-onset groups is more limited than for adult schizophrenia generally, so clinicians adapt methods to cognition, sensory access, mobility, and preference. NICE CG178 recommends individual CBT and family intervention for psychosis and schizophrenia.
Family education, social connection, and daily living
Family psychoeducation can clarify symptom patterns, help relatives respond to distress, support treatment decisions, and reduce avoidable conflict. Social support can address practical isolation, transport difficulties, food access, medication organization, housing concerns, and opportunities for meaningful activity. Hearing aids, glasses, sleep support, treatment of chronic illness, occupational approaches, and assistance with benefits or care coordination may make an important difference even when symptoms persist. These interventions address the person's quality of life as well as symptom severity.
First-Episode Psychosis After 60: How Quickly Should Care Begin?
The phrase first-episode psychosis describes a first recognized episode, regardless of whether the person is young or old. New psychosis in later life should receive timely assessment because acute medical causes may need urgent treatment. After the initial medical evaluation, specialist psychiatric care can address continuing symptoms and coordinate social support. NICE CG178 explicitly states that early-intervention psychosis services should be accessible to people with a first episode irrespective of age.
Coordinated specialty care integrates mental-health treatment, medication management, psychotherapy, family support, and help with practical functioning. Much of the trial evidence comes from younger first-episode populations. Services should preserve the collaborative principles while tailoring the approach to older adults rather than assuming identical outcomes or needs. Our first-episode psychosis guide and coordinated specialty care article cover the wider pathways.
When Is New Psychosis in an Older Adult an Emergency?
Urgent medical evaluation is warranted when hallucinations or delusions appear suddenly, especially with confusion, fever, dehydration, marked sleepiness, head injury, seizure, severe headache, weakness, breathing problems, or a substantial change in consciousness. These features may indicate delirium or another acute illness. Get immediate emergency help when the person may imminently harm themselves or others, cannot maintain basic safety, has severe agitation with medical instability, or develops catatonia-like immobility, rigidity, or inability to eat or drink. The appropriate response is a local emergency medical service or emergency department.
If the person is distressed but medically stable, arrange prompt evaluation through their physician or mental-health service. Avoid confronting or humiliating them about a belief, and avoid delaying medical attention while debating whether the experience is real. Ask calm, direct questions about safety, food and fluid intake, medication changes, and the timeline of symptoms. A supportive response can coexist with firm action when immediate safety is at stake.
How Can Family Members Respond to Suspiciousness or Hallucinations?
Start by acknowledging the person's experience and emotional response. Statements such as “That sounds frightening; I want to help you feel safe” communicate concern without endorsing a belief that has not been established. Listen for practical issues that can be checked, including possible mistreatment, break-ins, misplaced belongings, or threats. Provide orientation information gently, reduce unnecessary noise, and ensure glasses or hearing aids are available. Preserve privacy and autonomy wherever possible.
A concise written history can help clinicians enormously: when symptoms began; whether they fluctuate; the person's usual cognitive function; recent infections, falls, and sleep changes; all current medicines and recent dose adjustments; hearing or vision changes; and any threats to nutrition, money, housing, or personal safety. Ask the person how they want family involved. When decision-making capacity is impaired, clinical teams should follow applicable consent, safeguarding, and supported-decision frameworks.
Do not secretly change medications, withhold essential treatment, or set up a confrontation designed to expose a delusion. A collaborative plan may include scheduled clinical review, named contact people, preferred communication methods, and agreed steps if symptoms escalate. Families also need practical support and respite. Our guide to helping someone experiencing psychosis addresses communication and safety in more detail.
Outlook, Recovery, and Quality of Life
The course of later-life schizophrenia-spectrum illness varies. Some people improve substantially with treatment; others have recurring symptoms or need ongoing support. Symptoms may change as physical health, cognition, social circumstances, and medication tolerance change. Outcomes should be considered in several dimensions: symptom distress, meaningful relationships, autonomy, daily activities, housing, physical health, and the person's own priorities. A diagnostic term does not supply a reliable individual forecast.
Long-term follow-up should remain attentive to cognition and neurological signs without treating future dementia as inevitable. Continued assessment also helps identify potentially reversible causes of a new deterioration. The combination of psychiatric care, general medical care, sensory support, and sustained social connection can help preserve dignity and functioning. NIMH's schizophrenia information frames treatment in terms of functional and personal recovery rather than symptoms alone.
Frequently Asked Questions
Can schizophrenia really start at 50 or 60?
Yes. Although schizophrenia usually begins earlier, genuine first-onset schizophrenia-spectrum psychosis can occur in midlife and later life. The older the age at onset, the more important it becomes to evaluate medical, medication-related, delirium, and neurocognitive explanations before confirming a diagnosis.
Is late-onset schizophrenia a separate DSM-5-TR diagnosis?
No. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis are descriptive research and clinical terms grounded in an international consensus. Current diagnostic systems classify the underlying disorder according to its established criteria rather than providing an entirely separate age-defined schizophrenia diagnosis.
What is the difference between late-onset schizophrenia and very-late-onset schizophrenia-like psychosis?
In the influential international consensus, the former generally begins after age 40 and before 60, while the latter describes schizophrenia-like psychosis beginning after 60. These thresholds support research and clinical discussion but do not independently prove a cause.
Can hearing loss or social isolation cause delusions?
Sensory loss and isolation may complicate perception, interpretation, and functioning and have been associated with some late-onset presentations. Neither is sufficient to establish a causal psychiatric diagnosis. Clinicians investigate actual environmental issues, sensory impairments, cognitive changes, and medical conditions together.
How can a family tell the difference between dementia and schizophrenia?
Family observations about onset speed, progressive memory or functional change, fluctuating attention, movement symptoms, and hallucination type can guide assessment but cannot establish the diagnosis. Delirium should be considered when there is a sudden change. Clinicians may need repeated cognitive and neurological evaluation over time.
Do hallucinations always mean psychosis or schizophrenia?
No. Hallucinations can occur in several neurological, medical, psychiatric, substance-related, sleep-related, and sensory contexts. Their significance depends on the full pattern and history. A first hallucination in an older adult warrants professional evaluation, especially if accompanied by confusion or functional decline.
Is medication always necessary?
The answer depends on the cause, level of distress, safety, functioning, and informed preferences. A reversible medication reaction or delirium requires treatment of the underlying problem. For confirmed primary schizophrenia-spectrum psychosis, antipsychotic medication is a standard evidence-based option, often alongside psychological and psychosocial support. A clinician and patient should discuss benefits, risks, and monitoring.
Will very-late-onset schizophrenia-like psychosis progress to dementia?
Not necessarily. Research finds an association between VLOSLP and subsequent dementia diagnoses, but it cannot predict any person's future from psychosis alone. Follow-up should assess cognition, movement, sleep, and everyday functioning while responding to treatable concerns.
Can an older person recover after a first psychotic episode?
Yes. Improvement in symptoms, distress, independence, and quality of life is possible, although individual courses differ. Recovery-oriented care combines appropriate treatment of the underlying diagnosis, attention to medical health, collaboration, and practical support.
Related Articles
References
American Psychiatric Association. (2020). The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. Official APA practice guideline.
Howard, R., Rabins, P. V., Seeman, M. V., & Jeste, D. V. (2000). Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: An international consensus. American Journal of Psychiatry, 157(2), 172–178. DOI: 10.1176/appi.ajp.157.2.172.
Howard, R., et al. (2018). Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): A randomized, controlled, double-blind trial. The Lancet Psychiatry, 5(7), 553–563. Peer-reviewed article (PMCID: PMC6015223).
Kim, K., et al. (2022). Clinical approaches to late-onset psychosis. Journal of Personalized Medicine, 12(3), 381. DOI: 10.3390/jpm12030381.
MedlinePlus. (n.d.). Aripiprazole: Drug information and warning for older adults with dementia. National Library of Medicine.
National Institute for Health and Care Excellence. (2010; updated 2023). Delirium: Prevention, diagnosis and management in hospital and long-term care (CG103). Official NICE recommendations.
National Institute for Health and Care Excellence. (2014). Psychosis and schizophrenia in adults: Prevention and management (CG178). Official NICE recommendations.
National Institute of Mental Health. (n.d.). Schizophrenia. NIMH clinical information.
National Institute on Aging. (n.d.). Lewy body dementia: Causes, symptoms, and diagnosis. NIA official information.
Ng, I. K. S., Chua, J. W., Lui, Y. S., & Teo, D. B. S. (2023). Approach to acute psychosis in older adults. Singapore Medical Journal, 64(6), 391–397. DOI: 10.4103/singaporemedj.SMJ-2022-150.
Stafford, J., et al. (2023). Association between risk of dementia and very late-onset schizophrenia-like psychosis: A Swedish population-based cohort study. Psychological Medicine, 53(3), 750–758. DOI: 10.1017/S0033291721002099.